We are analyzing https://link.springer.com/article/10.1007/s12032-009-9301-1.

Title:
Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients | Medical Oncology
Description:
The aim of this study was to analyze the concentration of anti-p53 antibodies in the serum of breast cancer patients and to correlate these results with various clinical, pathological and biochemical parameters. We also wanted to assess the prognostic significance of these antibodies in our patients. Sera from 61 patients with breast cancer and 20 individuals without malignancies were analyzed using enzyme-linked immunoadsorbent assay. High levels of anti-p53 antibodies were detected in twenty-one (35%) breast cancer patients and one control (5%). The difference was statistically significant. We observed an inverse relationship between the anti-p53 antibodies and the age of the patients. We found significant association of anti-p53 antibodies with tumor size, histological grade of the tumors and the number of axillary lymph nodes involved. The levels of anti-p53 antibodies were higher in patients with negative estrogen and progesterone receptors in comparison with patients with positive steroid receptors, but the difference was not statistically significant. No relation was observed between anti-p53 antibodies neither with the Cathepsin D levels in the cytosol nor with the HER-2/neu extracellular domain in the serum. Patients with primary tumors and higher levels of anti-p53 antibodies had shorter 5-year survival than patients with lower levels of anti-p53 antibodies. Our results support the role of anti-p53 antibodies as a biomarker of less favorable phenotype as well as a prognostic factor for patients with breast cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

cancer, google, scholar, pubmed, breast, article, cas, patients, antibodies, serum, antip, res, autoantibodies, tumor, prognostic, human, int, oncol, privacy, cookies, content, oncology, relationship, prognosis, kulić, levels, access, detection, correlation, zagreb, publish, search, medical, sirotkovićskerlev, jelisavacćosić, study, significance, sera, assay, significant, types, markers, usa, nature, protein, croatia, receptor, response, data, information,

Topics {✒️}

month download article/chapter anti-p53 antibody response anthracycline-based neoadjuvant chemotherapy enzyme-linked immunoadsorbent assay anti-p53 antibodies increases population-based epidemiological study serum anti-p53 antibodies serum ant-p53 antibodies full article pdf privacy choices/manage cookies conventional tumor markers breast cancers university hospital center anti-p53 antibodies advanced breast cancer p53 proto-oncogene systemic therapy circulating p53 antibodies medical oncology gene p53 mutations mutant p53 protein human breast cancer european economic area scope submit manuscript 2/neu extracellular domain shorter 5-year survival related subjects changing global patterns immunodominant epitopes unrelated mutational hot spot folia histochem cytobiol p53 auto-antibodies locoregional breast cancer breast cancer relapse metastatic breast cancer p53/hsp70 complexes serum p53 antibodies conditions privacy policy cancer detect prev cellular protein p53 genet mol res positive steroid receptors hr/rak/novo invasive ductal carcinoma yeast functional assay carcino-embryonic antigen breast cancer res primary breast cancer found significant association croatian health service

Questions {❓}

Can serum autoantibodies be a potential early detection biomarker for breast cancer in women?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients
         description:The aim of this study was to analyze the concentration of anti-p53 antibodies in the serum of breast cancer patients and to correlate these results with various clinical, pathological and biochemical parameters. We also wanted to assess the prognostic significance of these antibodies in our patients. Sera from 61 patients with breast cancer and 20 individuals without malignancies were analyzed using enzyme-linked immunoadsorbent assay. High levels of anti-p53 antibodies were detected in twenty-one (35%) breast cancer patients and one control (5%). The difference was statistically significant. We observed an inverse relationship between the anti-p53 antibodies and the age of the patients. We found significant association of anti-p53 antibodies with tumor size, histological grade of the tumors and the number of axillary lymph nodes involved. The levels of anti-p53 antibodies were higher in patients with negative estrogen and progesterone receptors in comparison with patients with positive steroid receptors, but the difference was not statistically significant. No relation was observed between anti-p53 antibodies neither with the Cathepsin D levels in the cytosol nor with the HER-2/neu extracellular domain in the serum. Patients with primary tumors and higher levels of anti-p53 antibodies had shorter 5-year survival than patients with lower levels of anti-p53 antibodies. Our results support the role of anti-p53 antibodies as a biomarker of less favorable phenotype as well as a prognostic factor for patients with breast cancer.
         datePublished:2009-09-11T00:00:00Z
         dateModified:2009-09-11T00:00:00Z
         pageStart:887
         pageEnd:893
         sameAs:https://doi.org/10.1007/s12032-009-9301-1
         keywords:
            Anti-p53 antibodies
            Breast cancer
            Prognosis
            Clinicopathological correlation
            Oncology
            Hematology
            Pathology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig6_HTML.gif
         isPartOf:
            name:Medical Oncology
            issn:
               1559-131X
               1357-0560
            volumeNumber:27
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:A. Kulić
               affiliation:
                     name:University Hospital Center Zagreb
                     address:
                        name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
                     name:Zagreb Medical School
                     address:
                        name:Zagreb Medical School, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:M. Sirotković-Skerlev
               affiliation:
                     name:University Hospital Center Zagreb
                     address:
                        name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
                     name:Zagreb Medical School
                     address:
                        name:Zagreb Medical School, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Jelisavac-Ćosić
               affiliation:
                     name:University Hospital Center Zagreb
                     address:
                        name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
                     name:Zagreb Medical School
                     address:
                        name:Zagreb Medical School, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Herceg
               affiliation:
                     name:University Hospital Center
                     address:
                        name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Z. Kovač
               affiliation:
                     name:University Hospital Center Zagreb
                     address:
                        name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
                     name:Zagreb Medical School
                     address:
                        name:Zagreb Medical School, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Vrbanec
               affiliation:
                     name:University Hospital Center
                     address:
                        name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients
      description:The aim of this study was to analyze the concentration of anti-p53 antibodies in the serum of breast cancer patients and to correlate these results with various clinical, pathological and biochemical parameters. We also wanted to assess the prognostic significance of these antibodies in our patients. Sera from 61 patients with breast cancer and 20 individuals without malignancies were analyzed using enzyme-linked immunoadsorbent assay. High levels of anti-p53 antibodies were detected in twenty-one (35%) breast cancer patients and one control (5%). The difference was statistically significant. We observed an inverse relationship between the anti-p53 antibodies and the age of the patients. We found significant association of anti-p53 antibodies with tumor size, histological grade of the tumors and the number of axillary lymph nodes involved. The levels of anti-p53 antibodies were higher in patients with negative estrogen and progesterone receptors in comparison with patients with positive steroid receptors, but the difference was not statistically significant. No relation was observed between anti-p53 antibodies neither with the Cathepsin D levels in the cytosol nor with the HER-2/neu extracellular domain in the serum. Patients with primary tumors and higher levels of anti-p53 antibodies had shorter 5-year survival than patients with lower levels of anti-p53 antibodies. Our results support the role of anti-p53 antibodies as a biomarker of less favorable phenotype as well as a prognostic factor for patients with breast cancer.
      datePublished:2009-09-11T00:00:00Z
      dateModified:2009-09-11T00:00:00Z
      pageStart:887
      pageEnd:893
      sameAs:https://doi.org/10.1007/s12032-009-9301-1
      keywords:
         Anti-p53 antibodies
         Breast cancer
         Prognosis
         Clinicopathological correlation
         Oncology
         Hematology
         Pathology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-009-9301-1/MediaObjects/12032_2009_9301_Fig6_HTML.gif
      isPartOf:
         name:Medical Oncology
         issn:
            1559-131X
            1357-0560
         volumeNumber:27
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:A. Kulić
            affiliation:
                  name:University Hospital Center Zagreb
                  address:
                     name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
                  name:Zagreb Medical School
                  address:
                     name:Zagreb Medical School, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:M. Sirotković-Skerlev
            affiliation:
                  name:University Hospital Center Zagreb
                  address:
                     name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
                  name:Zagreb Medical School
                  address:
                     name:Zagreb Medical School, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Jelisavac-Ćosić
            affiliation:
                  name:University Hospital Center Zagreb
                  address:
                     name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
                  name:Zagreb Medical School
                  address:
                     name:Zagreb Medical School, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Herceg
            affiliation:
                  name:University Hospital Center
                  address:
                     name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Z. Kovač
            affiliation:
                  name:University Hospital Center Zagreb
                  address:
                     name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
                  name:Zagreb Medical School
                  address:
                     name:Zagreb Medical School, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Vrbanec
            affiliation:
                  name:University Hospital Center
                  address:
                     name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Medical Oncology
      issn:
         1559-131X
         1357-0560
      volumeNumber:27
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University Hospital Center Zagreb
      address:
         name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
         type:PostalAddress
      name:Zagreb Medical School
      address:
         name:Zagreb Medical School, Zagreb, Croatia
         type:PostalAddress
      name:University Hospital Center Zagreb
      address:
         name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
         type:PostalAddress
      name:Zagreb Medical School
      address:
         name:Zagreb Medical School, Zagreb, Croatia
         type:PostalAddress
      name:University Hospital Center Zagreb
      address:
         name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
         type:PostalAddress
      name:Zagreb Medical School
      address:
         name:Zagreb Medical School, Zagreb, Croatia
         type:PostalAddress
      name:University Hospital Center
      address:
         name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
         type:PostalAddress
      name:University Hospital Center Zagreb
      address:
         name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
         type:PostalAddress
      name:Zagreb Medical School
      address:
         name:Zagreb Medical School, Zagreb, Croatia
         type:PostalAddress
      name:University Hospital Center
      address:
         name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:A. Kulić
      affiliation:
            name:University Hospital Center Zagreb
            address:
               name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
               type:PostalAddress
            type:Organization
            name:Zagreb Medical School
            address:
               name:Zagreb Medical School, Zagreb, Croatia
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:M. Sirotković-Skerlev
      affiliation:
            name:University Hospital Center Zagreb
            address:
               name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
               type:PostalAddress
            type:Organization
            name:Zagreb Medical School
            address:
               name:Zagreb Medical School, Zagreb, Croatia
               type:PostalAddress
            type:Organization
      name:S. Jelisavac-Ćosić
      affiliation:
            name:University Hospital Center Zagreb
            address:
               name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
               type:PostalAddress
            type:Organization
            name:Zagreb Medical School
            address:
               name:Zagreb Medical School, Zagreb, Croatia
               type:PostalAddress
            type:Organization
      name:D. Herceg
      affiliation:
            name:University Hospital Center
            address:
               name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
               type:PostalAddress
            type:Organization
      name:Z. Kovač
      affiliation:
            name:University Hospital Center Zagreb
            address:
               name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
               type:PostalAddress
            type:Organization
            name:Zagreb Medical School
            address:
               name:Zagreb Medical School, Zagreb, Croatia
               type:PostalAddress
            type:Organization
      name:D. Vrbanec
      affiliation:
            name:University Hospital Center
            address:
               name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
      name:Zagreb Medical School, Zagreb, Croatia
      name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
      name:Zagreb Medical School, Zagreb, Croatia
      name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
      name:Zagreb Medical School, Zagreb, Croatia
      name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
      name:Department of Pathophysiology, University Hospital Center Zagreb, Zagreb, Croatia
      name:Zagreb Medical School, Zagreb, Croatia
      name:Department of Medical Oncology, Division of Oncology, University Hospital Center, Zagreb, Croatia
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(152)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.72s.

LINK . SPRINGER . COM {}